Search

Rhinology, Sofia and freedom

Our president-elect and host of the ERS2023 shares her love for ERS, rhinology in general, and Bulgaria. Let her invitation to experience the “freedom to breathe” inspire us all to visit Sophia and enjoy a great congress in a fantastic...

Andreas Wagner: ESPO 2025 keynote speaker

The keynote speaker for ESPO 2025 in Stuttgart is renowned evolutionary biologist and author Professor Andreas Wagner, from Zurich. Prof Wagner will focus on the congress theme of ‘Innovation’, giving us his unique perspective on how evolution drives human creativity....

Victoria Possamai, Consultant Paediatric ENT Surgeon - A Tribute

Victoria Possamai, Consultant Paediatric ENT Surgeon, Evelina London Children’s Hospital. 30 August 1977 – 6 December 2024 It is with great sadness that we reflect on the loss of our wonderful colleague and friend Victoria ‘Vikki’ Possamai, Consultant Paediatric ENT...

High intensity, high impact: tackling waiting lists one HIT at a time

A monthly high intensity theatre list in Sheffield shows how smart planning, teamwork and focus can dramatically reduce long ENT waiting lists. Finally, after many years of training, I’ve started my first consultant post – only to become part of...

Help shape the future of mild to moderate hearing loss research

A James Lind Alliance Priority Setting Partnership has been formed to help shape the future of research into mild-moderate hearing loss. Who is the Priority Setting Partnership? The Partnership brings together Hearing Link, Action on Hearing Loss, the British Society...

The impact of hearing loss in children with Down syndrome

Hearing loss and language development Down syndrome (DS) usually arises due to trisomy 21 and is associated with intellectual disability and risks of developmental delays and difficulties, including hearing loss. Hearing loss is common in children with DS [1]. In...

Clinical WG1. Establishing a standard for tinnitus: patient assessment and characterisation

Rilana Cima and Haúla Haider introduce an ambitious pan-European collaboration that seeks to establish guidelines for achieving best clinical practice for managing, assessing and treating patients with different tinnitus profiles. Tinnitus heterogeneity is the major reason for inconsistent results in...

Genetics WG4. Improving diagnosis and drug development through the genetic understanding of tinnitus subtypes: a TINNET endeavour

Christopher R Cederroth and Jose Antonio Lopez-Escamez explain how progress is being made to investigate the contribution of genetic factors to tinnitus, including a subtype of ‘extreme’ tinnitus in Ménière’s disease. Genetics WG4 is working towards determining the genetic basis...

2020 Lancet Commission on dementia: a call to action for integrated hearing healthcare

Dr Georgiou’s summary of the 2020 update to the 2017 Lancet Commission underscores the importance of medical and hearing healthcare professionals working together to tackle the modifiable risk factors that affect individuals throughout their lives, to help delay or even...

Listening differences in autistic individuals

In this article Erin Schafer, Lauren Mathews and Andrea Dunn outline the common auditory issues that autistic individuals face in comparison with their neurotypical peers and highlight the need to move beyond the traditional audiologic test battery when working with...

Rapid genetic testing to avoid hearing loss in neonates

Thousands of newborn babies could avoid a lifetime of hearing loss thanks to a new rapid genetic test. In this article, we learn how. We have demonstrated for the first time that a rapid genetic test from a cheek swab...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.